Abstract
Structural modifications were carried out on rebeccamycin, an antitumour antibiotic, to obtain analogues. The inhibitory potencies of these analogues against protein kinase C are compared. The method described represents an alternative route to the staurosporin aglycone, a potent protein kinase C inhibitor.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
